Xos, Inc. Form 8-K Summary
Business context and reporting period
Xos, Inc. filed a Current Report on Form 8-K dated December 28, 2022, reporting a Nasdaq listing deficiency. The filing does not present quarterly or annual operating results.
Financial metrics and liquidity
The filing does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material change versus the prior comparable period
On December 28, 2022, Nasdaq notified the company that Xos common stock had closed below the required minimum bid price of $1.00 per share for 30 consecutive business days. This was a deficiency notice, not an immediate delisting, and the stock continued trading on the Nasdaq Global Market under the symbol XOS.
Guidance, outlook, risks, and contingencies
- Xos received a 180-calendar-day compliance period ending June 26, 2023, to regain compliance with Nasdaq Listing Rule 5450(a)(1).
- Compliance generally requires a closing bid price of at least $1.00 for a minimum of 10 consecutive business days, subject to possible Nasdaq discretion.
- If compliance is not restored, Xos may be eligible for an additional 180-day period by applying to transfer its listing to the Nasdaq Capital Market and satisfying applicable requirements.
- The company stated that it may consider available measures, including a reverse stock split, if necessary, but provided no commitment or timing for such action.
- If Nasdaq determines that Xos cannot cure the deficiency or is otherwise ineligible, the common stock could be subject to delisting. The company would have appeal rights, and trading would generally continue during the appeal process.
- Management cautioned that there is no assurance the company will regain compliance during the initial or any additional compliance period or remain compliant with other Nasdaq listing standards.
Most important facts to verify
- Whether Xos restored a closing bid price of at least $1.00 for the required period by June 26, 2023.
- Whether Nasdaq granted an additional compliance period or issued a delisting determination.
- Whether Xos implemented or proposed a reverse stock split.
- Whether the company remained compliant with Nasdaq’s other continued-listing requirements.
- Subsequent SEC filings describing the effect of the listing deficiency on the company’s operations, financing, and securities.